Obvius Robotics Announces New Facility as it Prepares for Commercial Launch of CERTA Access System

It’s June fourth, twenty-twenty-four, and the medical device world is buzzing. Obvius Robotics, Inc., a company on a mission to, like, totally revolutionize vascular access, just dropped a major announcement: they’re opening a brand-spanking-new development and operations facility in sunny South Florida.

This isn’t just about more space for ping pong tables and kombucha on tap (though we’re sure they’ll have those too). This new facility is all about gearing up for the highly anticipated regulatory clearance and commercial launch of their game-changing CERTA Access System.

About Obvius Robotics

Obvius Robotics isn’t your average medical device company. These guys are all about democratizing vascular access – basically, making it easier and safer for everyone. They’re laser-focused on developing cutting-edge technology that’s so intuitive, even your grandma could use it (almost).

Their first target? Central venous catheterization, or CVC, a procedure that’s about as common in hospitals as bad coffee. While headquartered in South Florida, Obvius also has clinical offices at the super prestigious Texas Medical Center in Houston – talk about street cred!

The CERTA Access System

So, what’s all the hype about? Let’s talk about CERTA. Imagine a hand-held device, so sleek and futuristic it wouldn’t look out of place in a sci-fi movie. Now, picture this device in the hands of a clinician, effortlessly guiding them to the perfect spot for vascular access. That’s CERTA, baby!

This isn’t just some fancy imaging tool. CERTA allows clinicians to target anatomical structures with one hand (because who has time for two-handed procedures these days?). With a simple button push, their proprietary targeting system and needle assembly do the rest. You could say it’s like GPS for your veins, but way cooler.

And the best part? Early clinical use is showing a mind-blowing one-hundred percent access success rate. Yeah, you read that right – one-hundred percent. While it’s not yet approved for clinical use, Obvius Robotics is currently prepping CERTA for its grand debut to the FDA.

Significance of CVC and Challenges

Okay, so we’ve established that CERTA sounds pretty awesome, but why all the fuss about CVC in the first place? Well, my friend, CVC is basically the bread and butter of hospital procedures – it’s the most common interventional procedure in the United States.

Think about it: need to replace blood volume quickly? CVC. Emergency meds or pain relief? CVC. Want to keep tabs on a patient’s vital signs? You guessed it – CVC. It’s like the Swiss Army knife of medical procedures.

But here’s the catch: despite being so common, CVC can be kinda tricky. I mean, you’re literally sticking a needle into a major vein, like the jugular, subclavian, or femoral. Not exactly a walk in the park.

And with great power comes, well, a not-so-great complication rate. Due to factors like, ahem, lack of training and experience, CVC procedures can have a complication rate of four to eleven percent. Not exactly the kind of odds you want when it comes to your veins.

Obvius Robotics’ Vision for CERTA

This is where Obvius Robotics swoops in with their superhero capes (metaphorically, of course). Their vision for CERTA goes way beyond just making a cool gadget; they want to seriously shake things up in the medical world.

First, they want to democratize access to CVC procedures. Remember that whole “intuitive, even your grandma could use it” thing? They’re serious. By making CERTA user-friendly, they’re hoping to empower a wider range of healthcare professionals to perform CVC safely and effectively.

Second, and perhaps most importantly, they’re all about improving patient outcomes. Less complications = happier patients, and that’s a win-win for everyone.

But Obvius Robotics isn’t stopping there. They’re aiming high, folks – they want CERTA to become the gold standard for CVC. And with its impressive early results, they just might be on to something.

But wait, there’s more! The company has even bigger plans for the future. Think beyond CVC – they’re looking to expand the CERTA platform to a whole slew of new medical applications. World domination? Maybe. Improving healthcare? Definitely.

The New Facility: A Hub of Innovation

So back to that shiny new facility in South Florida. This isn’t just a random office building; it’s a strategic move by Obvius Robotics to support their ambitious goals.

This state-of-the-art space will house everything from research and development to manufacturing and operations, all under one roof. It’s like the Batcave of medical innovation, but with probably less brooding.

But it’s not just about bricks and mortar. The new facility will create high-paying jobs and attract top talent to the area, further cementing South Florida’s reputation as a hub for medical technology.

In the words of Russell Seiber, Obvius Robotics’ fearless leader: “The goal of Obvius Robotics is to democratize access, improve outcomes, and become the new standard of care in CVC. The new facility will not only support development and production of the CERTA Access System for CVC, but will also be a center of innovation to expand the CERTA platform into new applications.”

So there you have it – a groundbreaking medical device, a company with a bold vision, and a brand new facility to make it all happen. Obvius Robotics is definitely one to watch, and we can’t wait to see what they do next.

Disclaimer: The CERTA Access System is not yet approved or cleared for use in patients anywhere in the world.